In the press

El ObservadorStrategy, judges and three key minutes: Xeptiva Therapeutics at South Summit Brazil 2026See more ↗ El ObservadorXeptiva Therapeutics selected as a finalist at the South Summit Brazil 2026 Startup CompetitionSee more ↗ ACCESS NewswireAthos Therapeutics and Xeptiva Therapeutics announce partnership to discover vaccine biomarkersSee more ↗ Canal 10Xeptiva: Uruguayan biotechnology startupSee more ↗ TelenocheUruguayan scientists create a vaccine to treat chronic pain in dogsSee more ↗ 970 UniversalThe Uruguayan biotech start-up that caught the interest of the four largest laboratories in the worldSee more ↗ TelenocheUruguayan scientists test a vaccine against osteoarthritis in dogs and look for volunteersSee more ↗ Ciudad Viva · TV CiudadUp to 80% of dogs over 9–10 years may suffer from chronic osteoarthritis painSee more ↗ Locos x las MascotasFelipe’s storySee more ↗ Queremos SaberOsteoarticular vaccine for dogsSee more ↗ Locos x las MascotasEmiliano Trias, CSO, talks about Xeptiva’s storySee more ↗ TelemundoUruguayan scientists advance in research on chronic pain in dogsSee more ↗ Desayunos Informales · TeledocePolo’s storySee more ↗ Locos x las MascotasDr. Nadia Crosignani talks about Xeptiva’s clinical trialSee more ↗ Sobre Ciencia · TV CiudadHow is the first therapeutic vaccine entirely developed in Uruguay made?See more ↗ Locos x las MascotasFrodo’s storySee more ↗ El ObservadorJosefina Correa, CEO of Xeptiva, wins first prize at the VC LatAm Summit Miami 2025See more ↗ Canal 4Vaccine to treat chronic pain in animalsSee more ↗ Locos x las MascotasLocos por las Mascotas and Xeptiva Therapeutics interviewSee more ↗ ANII20% of adult dogs may suffer from chronic painSee more ↗ Canal 10Meet Felipe, one of the dogs in the clinical trialSee more ↗ Del Sol 99.5 FMVaccine against pain in dogsSee more ↗ TV clipFirst chronic pain vaccine developed by Xeptiva TherapeuticsSee more ↗ TelemundoUruguayan researchers and veterinarians seek to test the first vaccine against chronic pain in dogsSee more ↗ TelemundoA team of professionals created a biotech venture with an innovative treatment for dogsSee more ↗ Día a Día · VTVUruguayan scientists develop the first vaccine for chronic pain in dogsSee more ↗ Canal 5Uruguayan biotech start-up develops vaccines to relieve chronic pain in companion animalsSee more ↗ TV clipVaccine that treats chronic pain in dogsSee more ↗ Uruguay XXIXeptiva contributes to the growth of the Uruguayan scientific ecosystemSee more ↗ Canal 5Scientists develop a vaccine for chronic pain in companion animalsSee more ↗ Canal 4Vaccine against chronic pain in animalsSee more ↗ VTV NoticiasUruguayan scientists developed a vaccine from synthetically designed proteinsSee more ↗ Antena 3Vaccine for chronic pain in companion animals shows promise in early trialsSee more ↗ El PaísUruguayan scientists developed the first vaccine for chronic pain in dogs and catsSee more ↗ Institut Pasteur de MontevideoXeptiva moves closer to its first vaccine for chronic pain in companion animalsSee more ↗ Canal 5Everything about Xeptiva TherapeuticsSee more ↗ Este es el PlanJosefina Correa (CEO) and Emiliano Trias (CSO) on the biotech ecosystem in Uruguay and Xeptiva’s technologySee more ↗ TelenocheVeterinary school in Uruguay looks for dogs with chronic pain for an experimental vaccine studySee more ↗ TelenocheUruguayan scientists develop a vaccine for chronic painSee more ↗ El EspectadorVaccines to relieve chronic pain in petsSee more ↗ TelemundoThe Institut Pasteur and Xeptiva Therapeutics developed a vaccine to treat pain in petsSee more ↗ ÁmbitoSergio Fogel will invest millions in a company run by two young UruguayansSee more ↗ El ObservadorVentures with sustainable DNA: four young people who opted for triple impactSee more ↗ El ObservadorTime to become an investment magnetSee more ↗ Montevideo PortalA Uruguayan start-up advances in therapy to block pain in dogs, cats and horsesSee more ↗